Centennial Bank’s GSK GSK Stock Holding History

Centennial Bank’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.6K	Hold	164	–	–	﹤0.01%	297
2026 Q1	$9.05K	Hold	164	–	–	﹤0.01%	280
2025 Q4	$8.04K	Hold	164	–	–	﹤0.01%	289
2025 Q3	$7.08K	Hold	164	–	–	﹤0.01%	296
2025 Q2	$6.3K	Buy	+164	New	+$6.27K	﹤0.01%	308
2024 Q4	–	Sell	-139	Closed	-$5.68K	–	321
2024 Q3	$5.68K	Hold	139	–	–	﹤0.01%	295
2024 Q2	$5.35K	Hold	139	–	–	﹤0.01%	293
2024 Q1	$5.96K	Hold	139	–	–	﹤0.01%	294
2023 Q4	$5.15K	Sell	139 -6,843	-98%	-$246K	﹤0.01%	301
2023 Q3	$253K	Sell	6,982 -624	-8%	-$22.1K	0.18%	106
2023 Q2	$271K	Sell	7,606 -1,269	-14%	-$45.5K	0.18%	101
2023 Q1	$316K	Sell	8,875 -1,418	-14%	-$49.6K	0.21%	105
2022 Q4	$362K	Buy	+10,293	New	+$343K	0.21%	105

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Centennial Bank's GSK Position: Q2 2026 in Review

Centennial Bank held its GSK (GSK) position steady in Q2 2026 at 164 shares worth $8.6K. The position accounts for ﹤0.01% of the portfolio, ranked #297.

Centennial Bank first reported a position in GSK in Q4 2022 and has held it in 13 quarters since. The position peaked at $362K in Q4 2022. 1,043 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Centennial Bank held 164 shares of GSK worth $8.6K as of Q2 2026.
Centennial Bank left its GSK share count unchanged in Q2 2026.
GSK made up ﹤0.01% of Centennial Bank's portfolio in Q2 2026, its #297 holding.
Centennial Bank first reported a position in GSK in Q4 2022 and has held it in 13 quarters since.
Centennial Bank's GSK position peaked at $362K in Q4 2022.
1,043 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Centennial Bank's 13F filing for Q2 2026, filed 10 Aug 2026.